Calcium and Vitamin D for Bone Health: Review Finds Little Benefit

Calcium and vitamin D have long been treated as the default prescription for aging bones. Walk down any pharmacy aisle and the message is unmistakable: take these two, and you will hold osteoporosis at bay. But a growing body of pooled evidence suggests the relationship between supplementation and fracture prevention is far weaker than decades of marketing implied.

The pattern emerging from large systematic reviews is consistent. When researchers combine data from dozens of randomized trials involving hundreds of thousands of community-dwelling adults, supplements produce small increases in bone mineral density that do not translate into meaningful reductions in hip fractures or total fractures. Bone density, it turns out, is a useful laboratory marker but an imperfect stand-in for the outcome patients actually care about: breaking a bone.

Why the gap between density and fractures?

Bone strength depends on more than mineral content. Architecture, collagen quality, turnover rate and the mechanical loading bones receive from daily movement all contribute. A modest bump in density, often in the range of one to two percent, can register on a DEXA scan while doing little to change whether a hip survives a sideways fall.

Falls themselves are the other half of the equation. Most fragility fractures in older adults begin with a loss of balance. Muscle strength, vision, blood pressure regulation, footwear and medication side effects influence fall risk far more than a daily tablet does. Interventions that address these factors tend to outperform supplementation in head-to-head comparisons.

Who may still benefit

The findings are not a blanket dismissal. Several groups appear in the evidence with genuinely different risk profiles:

• Institutionalized older adults, particularly nursing home residents with limited sun exposure and poor dietary intake, where combined calcium and vitamin D has shown fracture reduction in some trials.
• People with diagnosed vitamin D deficiency, confirmed by blood testing rather than assumed.
• Patients on corticosteroids or other bone-depleting medications, where supplementation is part of a broader treatment plan.
• Individuals with osteoporosis taking prescription bone therapies, since drugs such as bisphosphonates were tested alongside adequate calcium and vitamin D intake.

For a healthy adult eating a reasonably varied diet, the case is considerably thinner.

The question of harm

Supplements are not consequence-free. High-dose calcium has been linked to kidney stones and gastrointestinal complaints, and questions about cardiovascular effects have never been fully resolved. Very high intermittent doses of vitamin D have, in some trials, paradoxically increased falls. Modest risks matter more when the expected benefit is small.

What the evidence supports instead

Researchers converge on a set of less marketable recommendations. Dietary calcium from dairy, fortified plant milks, tinned fish with bones, tofu and leafy greens comes packaged with protein and other nutrients and carries none of the concerns attached to concentrated doses. Resistance training and weight-bearing exercise remain among the few interventions shown to improve both bone quality and fall resistance. Balance work, adequate protein intake, smoking cessation and a medication review with a physician round out the list.

None of this means throwing out an existing prescription. Anyone taking supplements on medical advice, particularly for osteoporosis, should raise the question at their next appointment rather than stopping independently. The reasonable takeaway is narrower than the headlines suggest: supplements are a targeted tool for specific patients, not a universal insurance policy for aging skeletons.